Profil

RONCARATI Patrick

Unilab > Laboratoire biologie moléculaire

See author's contact details
Main Referenced Co-authors
Delvenne, Philippe  (57)
Hubert, Pascale  (50)
Herfs, Michael  (47)
Bruyère, Diane  (28)
Hendrick, Elodie  (25)
Main Referenced Keywords
HPV (10); Humans (3); siRNA (3); Cancer (2); Cervical cancer (2);
Main Referenced Unit & Research Centers
Giga-Cancer - ULiège [BE] (4)
Centre Interfacultaire de Recherche du Médicament - CIRM (3)
Giga-Signal Transduction - ULiège [BE] (1)
Main Referenced Disciplines
Oncology (54)
Immunology & infectious disease (8)
Pharmacy, pharmacology & toxicology (3)
Biochemistry, biophysics & molecular biology (2)
Otolaryngology (1)

Publications (total 61)

The most downloaded
1415 downloads
Demoulin, S., RONCARATI, P., Delvenne, P., & Hubert, P. (2012). Production of large numbers of plasmacytoid dendritic cells with functional activities from CD34+ hematopoietic progenitor cells: use of IL-3. Experimental Hematology, 40 (4), 268-278. doi:10.1016/j.exphem.2012.01.002 https://hdl.handle.net/2268/111910

The most cited

97 citations (Scopus®)

Shostak, K., Zhang, X., Hubert, P., Göktuna, S., Jiang, Z., Klevernic, I., Hildebrand, J., Roncarati, P., Hennuy, B., Ladang, A., SOMJA, J., Gothot, A., Close, P., Delvenne, P., & Chariot, A. (2014). NF-kappaB-induced KIAA1199 promotes survival through EGFR signalling. Nature Communications, 5, 5232. doi:10.1038/ncomms6232 https://hdl.handle.net/2268/174135

Mourtada, J., Lony, C., Nicol, A., De Azevedo, J., Bour, C., Macabre, C., RONCARATI, P., Ledrappier, S., Schultz, P., Borel, C., Burgy, M., Wasylyk, B., Mellitzer, G., Herfs, M., Gaiddon, C., & Jung, A. C. (October 2023). A novel ΔNp63-dependent immune mechanism improves prognosis of HPV-related head and neck cancer. Frontiers in Immunology, 14, 1264093. doi:10.3389/fimmu.2023.1264093
Peer Reviewed verified by ORBi

Ancion, M., Luyckx, M., Renard, M., Reynders, C., Lerho, T., Bruyère, D., Hendrick, E., Pilard, C., RONCARATI, P., Herfs, M., & Hubert, P. (12 June 2023). Approach using "second generation" immune checkpoint inhibitors for the treatment of triple-negative breast cancer [Poster presentation]. EACR 2023, Turin, Italy.

Reynders, C., RONCARATI, P., Ancion, M., Lerho, T., Luyckx, M., Renard, M., Delvenne, P., Hubert, P., & Herfs, M. (02 February 2023). Histopathological characterization of esophageal tumors and potential involvement of high-risk HPV in carcinogenesis [Poster presentation]. Séminaire des chercheurs Télévie 2023.

Mohring, V., Hubert, P., Ancion, M., Nokin, M.-J., Roncarati, P., Agirman, F., Maloujahmoum, N., Lardinois, F., Wissocq, T., Herfs, M., Peulen, O., & Janji, B. (2023). Enhancement of anti-tumor immunity through interference with glycation stress in breast cancer [Poster presentation]. GIGA day.

Bruyere, D., RONCARATI, P., Lebeau, A., Lerho, T., Poulain, F., Hendrick, E., Pilard, C., Reynders, C., Ancion, M., Luyckx, M., Renard, M., Jacob, Y., Twizere, J.-C., Peiffer, R., Peulen, O., Delvenne, P., Hubert, P., McBride, A., Gillet, N., ... Herfs, M. (2023). Human papillomavirus E6/E7 oncoproteins promote radiotherapy-mediated tumor suppression by globally hijacking host DNA damage repair. Theranostics, 13 (3), 1130 - 1149. doi:10.7150/thno.78091
Peer Reviewed verified by ORBi

Reynders, C., Roncarati, P., Ancion, M., Lerho, T., Bruyère, D., Delvenne, P., Hubert, P., & Herfs, M. (29 September 2022). Caractérisations histopathologiques des cancers œsophagiennes et potentiel implication des infections par HPV de haut-risques [Paper presentation]. Conférence annuelle de l'Association Francophone pour l'étude des Infections à Papillomavirus et Polyomavirus 2022, France.

Reynders, C., RONCARATI, P., Ancion, M., Lerho, T., Pilard, C., Bruyère, D., Hendrick, E., Delvenne, P., Hubert, P., & Herfs, M. (09 September 2022). Histopathological characterization of esophageal tumors and potential involvement of high-risk HPV in carcinogenesis [Poster presentation]. INTERUNIVERSITY PHD STUDENT DAY.

Reynders, C., RONCARATI, P., Ancion, M., Lerho, T., Pilard, C., Hendrick, E., Bruyère, D., Delvenne, P., Hubert, P., & Herfs, M. (06 September 2022). Histopathological characterization of esophageal tumors and potential involvement of high-risk HPV infections in carcinogenesis [Poster presentation]. GIGA-Day 2022.

Reynders, C., RONCARATI, P., Ancion, M., Lerho, T., Bruyère, D., Hendrick, E., Pilard, C., Delvenne, P., Hubert, P., & Herfs, M. (29 April 2022). Histopathological characterization of esophageal tumors and potential involvement of high-risk HPV in carcinogenesis [Paper presentation]. Séminaire du GIGA-Cancer, Belgium.

Reynders, C., RONCARATI, P., Ancion, M., Lerho, T., Hendrick, E., Bruyère, D., Pilard, C., Delvenne, P., Hubert, P., & Herfs, M. (08 April 2022). Histopathological characterization of esophageal cancers and potential role of high-risk HPV infections [Poster presentation]. Séminaire des chercheurs Télévie 2022, Belgium.

Lebeau, A.* , Bruyère, D.* , RONCARATI, P., Peixoto, P., Hervouet, E., COBRAIVILLE, G., Taminiau, B., Masson, M., Gallego, C., Mazzucchelli, G., Smargiasso, N., Fleron, M., Baiwir, D., Hendrick, E., Pilard, C., Lerho, T., Reynders, C., Ancion, M., GREIMERS, R., ... Herfs, M. (28 February 2022). HPV infection alters vaginal microbiome through down-regulating host mucosal innate peptides used by Lactobacilli as amino acid sources. Nature Communications, 13 (1), 1076. doi:10.1038/s41467-022-28724-8
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Debernardi, A., Meurisse, A., Prétet, J.-L., Guenat, D., Monnien, F., Spehner, L., Vienot, A., RONCARATI, P., André, T., Abramowitz, L., Molimard, C., Mougin, C., Herfs, M., Kim, S., & Borg, C. (2022). Prognostic role of HPV integration status and molecular profile in advanced anal carcinoma: An ancillary study to the epitopes-HPV02 trial. Frontiers in Oncology, 12, 941676. doi:10.3389/fonc.2022.941676
Peer Reviewed verified by ORBi

Reynders, C., RONCARATI, P., Ancion, M., Lerho, T., Pilard, C., Bruyère, D., Hendrick, E., Delvenne, P., Hubert, P., & Herfs, M. (14 December 2021). Histopathological characterization of esophageal cancers and potential role of high-risk HPV infections [Poster presentation]. Giga Cancer Day 2021.

Reynders, C., RONCARATI, P., Ancion, M., Lerho, T., Bruyère, D., Hendrick, E., Pilard, C., Hubert, P., Delvenne, P., & Herfs, M. (01 October 2021). Caractérisation histopathologique des cancers œsophagiens et potentiel rôle des HPV [Paper presentation]. Conférence annuelle de l'Association Francophone pour l'étude des Infections à Papillomavirus et Polyomavirus, France.

Hubert, P., RONCARATI, P., Demoulin, S., Pilard, C., Ancion, M., Reynders, C., Lerho, T., Bruyère, D., Lebeau, A., Radermecker, C., Meunier, M., Nokin, M.-J., Hendrick, E., Peulen, O., Delvenne, P., & Herfs, M. (2021). Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy. Journal for ImmunoTherapy of Cancer, 9 ((3)), 001966. doi:10.1136/jitc-2020-001966
Peer Reviewed verified by ORBi

Bruyère, D., Monnien, F., Colpart, P., RONCARATI, P., Vuitton, L., Hendrick, E., Lepinoy, A., Luquain, A., Pilard, C., Lerho, T., Molimard, C., Maingon, P., Arnould, L., Bone-Lepinoy, M.-C., Dusserre, L., Martin, L., Reynders, C., Ancion, M., Peiffert, D., ... Herfs, M. (2021). Treatment algorithm and prognostic factors for patients with stage I–III carcinoma of the anal canal: a 20-year multicenter study. Modern Pathology, 34, 116-130. doi:10.1038/s41379-020-0637-6
Peer Reviewed verified by ORBi

Pilard, C., RONCARATI, P., Hendrick, E., Bruyère, D., Lerho, T., Ancion, M., Reynders, C., DELVENNE, P., Herfs, M., & Hubert, P. (03 November 2020). Combining PD-1/PD-L1 blockade and RANKL inhibitors to treat breast cancers unresponsive to standard therapy [Paper presentation]. Cytokines 2020, Seattle (Virtual), United States.

Pilard, C., RONCARATI, P., Hendrick, E., Bruyère, D., Lerho, T., Ancion, M., Reynders, C., DELVENNE, P., Herfs, M., & Hubert, P. (03 October 2020). Combining PD-1/PD-L1 blockade and RANKL inhibitors to treat breast cancers unresponsive to standard therapy [Poster presentation]. 7th Immunotherapy of Cancer Conference (ITOC7), Munich (Virtual), Germany.

Pilard, C., RONCARATI, P., Hendrick, E., Lebeau, A., Bruyère, D., Lerho, T., Ancion, M., Reynders, C., DELVENNE, P., Herfs, M., & Hubert, P. (01 October 2020). P08.03 Combining PD-1/PD-L1 blockade and RANKL inhibitors to treat breast cancers unresponsive to standard therapy. Journal for ImmunoTherapy of Cancer, 8 (Suppl 2), 50-A51. doi:10.1136/jitc-2020-ITOC7.99

Pilard, C., RONCARATI, P., Hendrick, E., Lebeau, A., Bruyère, D., Lerho, T., Ancion, M., Reynders, C., DELVENNE, P., Herfs, M., & Hubert, P. (07 February 2020). Combining PD-1/PD-L1 blockade and RANKL inhibitors to treat breast cancers unresponsive to standard therapy [Poster presentation]. BACR 2020, Jette, Belgium.

Pilard, C., RONCARATI, P., Hendrick, E., Lebeau, A., Bruyère, D., Lerho, T., Ancion, M., Reynders, C., DELVENNE, P., Herfs, M., & Hubert, P. (29 January 2020). Combining PD-1/PD-L1 blockade and RANKL inhibitors to treat breast cancers unresponsive to standard therapy [Poster presentation]. Télévie Seminar 2020, Bruxelles, Belgium.

Pilard, C., RONCARATI, P., Lebeau, A., Bruyère, D., Hendrick, E., DELVENNE, P., Herfs, M., & Hubert, P. (21 May 2019). Combining PD-1/PD-L1 blockade and RANKL inhibitors to treat breast cancers unresponsive to standard therapy [Poster presentation]. Immunology Day 2019, Liège, Belgium.

Pilard, C., RONCARATI, P., Lebeau, A., Bruyère, D., Hendrick, E., DELVENNE, P., Herfs, M., & Hubert, P. (01 February 2019). Combining PD-1/PD-L1 blockade and RANKL inhibitors to treat breast cancers unresponsive to standard therapy [Poster presentation]. BACR 2019, Anvers, Belgium.

Pilard, C., RONCARATI, P., Lebeau, A., Bruyère, D., Hendrick, E., DELVENNE, P., Herfs, M., & Hubert, P. (28 January 2019). Combining PD-1/PD-L1 blockade and RANKL inhibitors to treat breast cancers unresponsive to standard therapy [Poster presentation]. Télévie Seminar 2019, Gembloux, Belgium.

Nokin, M.-J., Bellier, J., Durieux, F., Peulen, O., Rademaker, G., Gabriel, M., Monseur, C., CHARLOTEAUX, B., Verbeke, L., van Laere, S., RONCARATI, P., Herfs, M., Lambert, C., Scheijen, J., Schalkwijk, C., Colige, A., Caers, J., Delvenne, P., Turtoi, A., ... Bellahcene, A. (2019). Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancer. Breast Cancer Research, 21(1, 11. doi:10.1186/s13058-018-1095-7
Peer Reviewed verified by ORBi

Pilard, C., RONCARATI, P., Lebeau, A., Bruyère, D., Hendrick, E., DELVENNE, P., Herfs, M., & Hubert, P. (13 September 2018). Combining PD-1/PD-L1 blockade and RANKL inhibitors to treat breast cancers unresponsive to standard therapy [Poster presentation]. GIGA-Cancer Day 2018, Liège, Belgium.

Bruyère, D., Lebeau, A., RONCARATI, P., Hendrick, E., Masson, M., Twizere, J.-C., Pilard, C., Hubert, P., DELVENNE, P., & Herfs, M. (30 May 2018). Deciphering the radiosensitivity of HPV-positive tumors [Poster presentation]. 5th meeting on emerging issues in oncogenic virus research, San Pietro in Bevagna, Italy.

Bruyère, D., Lebeau, A., RONCARATI, P., Hendrick, E., Masson, M., Twizere, J.-C., Pilard, C., Hubert, P., DELVENNE, P., & Herfs, M. (28 May 2018). Deciphering the radiosensitivity of HPV-positive tumors [Poster presentation]. EDT-Immunology day 2018, Liège, Belgium.

Lebeau, A., Bruyère, D., Hendrick, E., Pilard, C., RONCARATI, P., TAZIAUX, S., Hubert, P., Delvenne, P., & Herfs, M. (28 May 2018). HPV-related innate peptide inhibition promotes the acquisition of bacterial/fungal infections within the genital tract [Poster presentation]. Immunology day 2018, Liège, Belgium.

Lebeau, A., Bruyère, D., Hendrick, E., Pilard, C., RONCARATI, P., TAZIAUX, S., Hubert, P., Delvenne, P., & Herfs, M. (01 February 2018). HPV-related innate peptide inhibition promotes the acquisition of bacterial/fungal infections within the genital tract [Poster presentation]. Annual Televie seminar, Bruxelles, Belgium.

Herfs, M., RONCARATI, P., KOOPMANSCH, B., Peulen, O., Bruyère, D., Lebeau, A., Hendrick, E., Hubert, P., PONCIN, A., Penny, W., Piazzon, N., Monnien, F., Guenat, D., Mougin, C., Prétet, J.-L., Vuitton, L., SEGERS, K., LAMBERT, F., BOURS, V., ... Delvenne, P. (2018). A dualistic model of primary anal canal adenocarcinoma with distinct cellular origins, etiologies, inflammatory microenvironments and mutational signatures: implications for personalized medicine. British Journal of Cancer, 118(10), 1302-1312. doi:10.1038/s41416-018-0049-2
Peer Reviewed verified by ORBi

Lebeau, A., Bruyère, D., RONCARATI, P., DELVENNE, P., Hubert, P., & Herfs, M. (01 February 2017). HPV-mediated innate peptide down-regulation promotes the acquisition of bacterial/fungal infections within the genital tract [Poster presentation]. GIGA Day 2017, Liège, Belgium.

Herfs, M., Longuespée, R., Quick, C., RONCARATI, P., Suarez-Carmona, M., Hubert, P., Lebeau, A., Bruyère, D., Mazzucchelli, G., Smargiasso, N., Baiwir, D., Lai, K., Dunn, A., Obregon, F., Yang, E., De Pauw, E., Crum, C., & Delvenne, P. (2017). Proteomic signatures reveal a dualistic and clinically relevant classification of anal canal carcinoma. Journal of Pathology, 241, 522-533. doi:10.1002/path.4858
Peer Reviewed verified by ORBi

El-Shazly, A. E., Roncarati, P., Lejeune, M., Lefèbvre, P., & Delvenne, P. (2017). Tyrosine kinase inhibition is an important factor for gene expression of CRTH2 in human eosinophils and lymphocytes: A novel mechanism for explaining eosinophils recruitment by the neuro-immune axis in allergic rhinitis. International Immunopharmacology, 45 (45), 180-186. doi:10.1016/j.intimp.2017.02.015
Peer Reviewed verified by ORBi

Lebeau, A., Bruyère, D., RONCARATI, P., Delvenne, P., Hubert, P., & Herfs, M. (08 December 2016). HPV-mediated innate peptide down-regulation promotes the acquisition of bacterial/fungal infections within the genital tract [Poster presentation]. Televie Seminar, Bruxelles, Belgium.

Henry, A., Nokin, M.-J., Leroi, N., Lallemand, F., Lambert, J., Goffart, N., RONCARATI, P., BIANCHI, E., Peixoto, P., Blomme, A., Turtoi, A., Peulen, O., Habraken, Y., Scholtes, F., Martinive, P., Delvenne, P., Rogister, B., Castronovo, V., & Bellahcene, A. (2016). New role of osteopontin in DNA repair and impact on human glioblastoma radiosensitivity. Oncotarget. doi:10.18632/oncotarget.11483
Peer Reviewed verified by ORBi

Henry, A., Nokin, M.-J., Leroi, N., LALLEMAND, F., Lambert, J., Goffart, N., Peixoto, P., Blomme, A., BIANCHI, E., Habraken, Y., RONCARATI, P., Peulen, O., SCHOLTES, F., MARTINIVE, P., Rogister, B., Delvenne, P., Turtoi, A., Castronovo, V., & Bellahcene, A. (22 March 2016). Osteopontin predicts radiotherapy response of glioblastoma patients : new role in DNA damage repair [Paper presentation]. 3rd Symposium on small animal precision image-guided radiotherapy, Gand, Belgium.

Mirkovic, J., Howitt, B., RONCARATI, P., Demoulin, S., Suarez-Carmona, M., Hubert, P., Mckeon, F., Xian, W., Delvenne, P., Crum, C. P., & Herfs, M. (2015). Carcinogenic HPV infection in the cervical squamo-columnar junction. Journal of Pathology, 236, 265-271. doi:10.1002/path.4533
Peer Reviewed verified by ORBi

Demoulin, S., SOMJA, J., duray, A., guenin, S., RONCARATI, P., DELVENNE, P., Herfs, M.* , & Hubert, P.*. (2015). Cervical (pre)neoplastic microenvironment promotes the emergence of tolerogenic dendritic cells via RANKL secretion. Oncoimmunology, 6. doi:10.1080/2162402X.2015.1008334
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

BIANCHI, E., RONCARATI, P., HOUGRAND, O., Guérin-El Khourouj, V., BOREUX, R., Kroonen, J., Martin, D., Robe, P., Rogister, B., Delvenne, P., & Deprez, M. (2015). Human cytomegalovirus and primary intracranial tumours: Frequency of tumour infection and lack of correlation with systemic immune anti-viral responses. Neuropathology and Applied Neurobiology, 41 (2), 29-e40. doi:10.1111/nan.12172
Peer Reviewed verified by ORBi

Demoulin, S., Herfs, M., SOMJA, J., RONCARATI, P., Delvenne, P., & Hubert, P. (2015). HMGB1 secretion during cervical carcinogenesis promotes the acquisition of a tolerogenic functionality by plasmacytoid dendritic cells. International Journal of Cancer, 137, 345-358. doi:10.1002/ijc.29389
Peer Reviewed verified by ORBi

Pottier, C., Wheatherspoon, A., RONCARATI, P., Longuespée, R., Herfs, M., Duray, A., Delvenne, P., & Quatresooz, P. (2015). The importance of the tumor microenvironment in the therapeutic management of cancer. Expert Review of Anticancer Therapy, 15, 943-954. doi:10.1586/14737140.2015.1059279
Peer Reviewed verified by ORBi

Hubert, P.* , Herman, L.* , RONCARATI, P., Maillard, C., Renoux, V., Demoulin, S., Erpicum, C., Foidart, J.-M., Boniver, J., Noël, A., Delvenne, P., & Herfs, M. (2014). Altered alpha-defensin 5 expression in cervical squamocolumnar junction: implication in the formation of a viral/tumour-permissive microenvironment. Journal of Pathology, 234 (4), 464-77. doi:10.1002/path.4435
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Suarez-Carmona, M., Hubert, P., Gonzalez, A., Duray, A., RONCARATI, P., Erpicum, C., Boniver, J., Castronovo, V., Noël, A., Saussez, S., Peulen, O., Delvenne, P., & Herfs, M. (2014). DeltaNp63 isoform-mediated beta-defensin family up-regulation is associated with (lymph)angiogenesis and poor prognosis in patients with squamous cell carcinoma. Oncotarget, 5 (7), 1856-1868. doi:10.18632/oncotarget.1819
Peer Reviewed verified by ORBi

Shostak, K., Zhang, X., Hubert, P., Göktuna, S., Jiang, Z., Klevernic, I., Hildebrand, J., Roncarati, P., Hennuy, B., Ladang, A., SOMJA, J., Gothot, A., Close, P., Delvenne, P., & Chariot, A. (2014). NF-kappaB-induced KIAA1199 promotes survival through EGFR signalling. Nature Communications, 5, 5232. doi:10.1038/ncomms6232
Peer Reviewed verified by ORBi

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., RONCARATI, P., Piel, G., & Hubert, P. (05 December 2013). Development of anti-HPV lipoplexes formulations for the treatment of cervical cancer [Poster presentation]. Séminaire des chercheurs du Télévie 2014.

Demoulin, S., Somja, J., Herfs, M., RONCARATI, P., Delvenne, P., & Hubert, P. (December 2013). Implication of plasmacytoid dendritic cells in the malignant transformation of cervical epithelial metaplasia [Poster presentation]. 4th International Workshop on plasmacytoid dendritic cells, Paris, France.

Somja, J., Demoulin, S., RONCARATI, P., Herfs, M., BLETARD, N., Delvenne, P., & Hubert, P. (2013). Dendritic cells in Barrett's esophagus carcinogenesis: an inadequate microenvironment for antitumor immunity? American Journal of Pathology, 182, 2168-2179. doi:10.1016/j.ajpath.2013.02.036
Peer Reviewed verified by ORBi

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., RONCARATI, P., Piel, G., & Hubert, P. (2013). Development of anti-HPV lipoplexes for the treatment of cervical cancer [Poster presentation]. Cancer GIGA-Day 2013, liège, Belgium.

Lechanteur, A., Evrard, B., Delvenne, P., RONCARATI, P., Hubert, P., & Piel, G. (November 2012). Development and optimization of lipoplex vectors for an antisens therapeutic approach in the context of HPV induced lesions [Poster presentation]. Ecole doctorale en cancérologie expérimentale, liège, Belgium.

Demoulin, S., RONCARATI, P., Delvenne, P., & Hubert, P. (2012). Production of large numbers of plasmacytoid dendritic cells with functional activities from CD34+ hematopoietic progenitor cells: use of IL-3. Experimental Hematology, 40 (4), 268-278. doi:10.1016/j.exphem.2012.01.002
Peer reviewed

Demoulin, S., RONCARATI, P., Delvenne, P., & Hubert, P. (December 2011). Production of large numbers of plasmacytoid dendritic cells with functional activities from CD34+ hematopoietic progenitor cells: use of IL-3 [Poster presentation]. 3ème Atelier International "Cellules Dendritiques Plasmacytoïdes et Réponses Immunes", Paris, France.

Demoulin, S., Herfs, M., Somja, J., Delvenne, P., Hubert, P., & RONCARATI, P. (2011). Implication of plasmacytoid dendritic cells in the malignant transformation of cervical epithelial metaplasia [Poster presentation]. miRNA symposium, Namur, Belgium.

Demoulin, S., Herfs, M., Somja, J., RONCARATI, P., Boniver, J., Delvenne, P., & Hubert, P. (September 2010). Implication of plasmacytoid dendritic cells in the malignant transformation of cervical epithelial metaplasia [Poster presentation]. Cell Symposium on Inflammation and Disease, Lisbonne, Portugal.

El Shazly, A., Arafa, M., Roncarati, P., Dortu, E., Lefebvre, P., & Delvenne, P. (2010). Characterization of hepatitis C virus-induced nasal mucosa remodelling. Histopathology, 57 (3), 488-92. doi:10.1111/j.1365-2559.2010.03629.x
Peer Reviewed verified by ORBi

Herfs, M., Herman, L., Hubert, P., Minner, F., Arafa, M. M. M., Roncarati, P., Henrotin, Y., Boniver, J., & Delvenne, P. (April 2009). High expression of PGE2 enzymatic pathways in cervical (pre)neoplastic lesions and functional consequences for antigen-presenting cells. Cancer Immunology, Immunotherapy, 58 (4), 603-614. doi:10.1007/s00262-008-0584-4
Peer Reviewed verified by ORBi

Cloosen, S., Caberg, J.-H., Huls, M. B., Vanderlocht, J., Senden-Gilsbers, B. L. M. G., Roncarati, P., Hubert, P., Delvenne, P., Germeraad, W. T. V., & Bos, G. M. J. (February 2009). Surface Mucin-1 does not play a role in dendritic cell migration. Molecular Immunology, 46 (4), 738-742. doi:10.1016/j.molimm.2008.07.033
Peer Reviewed verified by ORBi

Caberg, J.-H., Hubert, P., Herman, L., Herfs, M., Roncarati, P., Boniver, J., & Delvenne, P. (January 2009). Increased migration of Langerhans cells in response to HPV16 E6 and E7 oncogene silencing: role of CCL20. Cancer Immunology, Immunotherapy, 58 (1), 39-47. doi:10.1007/s00262-008-0522-5
Peer Reviewed verified by ORBi

Caberg, J.-H., Hubert, P., Begon, D., Herfs, M., Roncarati, P., Boniver, J., & Delvenne, P. (July 2008). Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes. Carcinogenesis, 29 (7), 1441-7. doi:10.1093/carcin/bgn145
Peer Reviewed verified by ORBi

Renoux, V., de Leval, L., Waroux, O., Roncarati, P., Dortu, E., Gathy, R., Arafa, M., Boniver, J., Delvenne, P., & Jacobs, N. (2008). TCRγδ cells in HPV-associated cervical cancer. Acta Clinica Belgica, 63.
Peer Reviewed verified by ORBi

Jacobs, N., Renoux, V., Dortu, E., Arafa, M., de Leval, L., Roncarati, P., Boniver, J., & Delvenne, P. (12 April 2007). NK CELLS AND NKG2D LIGANDS IN HPV-ASSOCIATED CERVICAL CANCER [Poster presentation]. 10th Meeting of the Society for Natural Immunity, Cambridge, United Kingdom.

Contact ORBi